Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction
Open Access
- 1 January 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (1), 135-142
- https://doi.org/10.1038/mt.2009.257
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectorsJCI Insight, 2009
- Enhancement of Adeno-Associated Virus Infection by Mobilizing Capsids into and Out of the NucleolusJournal of Virology, 2009
- Treatment of Leber Congenital Amaurosis Due toRPE65Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I TrialHuman Gene Therapy, 2008
- Enhancing transduction of the liver by adeno-associated viral vectorsGene Therapy, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory ActivityJournal of Virology, 2008
- Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myelomaBlood, 2008
- Proteasome inhibition suppresses essential immune functions of human CD4+ T cellsImmunology, 2008
- Existence of transient functional double-stranded DNA intermediates during recombinant AAV transductionProceedings of the National Academy of Sciences, 2007